| Identification |
| Name: | 1,3-Cyclohexanediol,4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-methyl-1-[(1R,2E)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-,(1R,3S,5Z)- |
| Synonyms: | 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol,(1a,3b,5Z,7E,22E)- (9CI);1-Hydroxyergocalciferol;1-Hydroxyvitamin D2;1a-Hydroxyergocalciferol;1a-Hydroxyvitamin D2;Hectorol;TSA 840; |
| CAS: | 54573-75-0 |
| Molecular Formula: | C28H44O2 |
| Molecular Weight: | 412.64776 |
| InChI: | InChI=1S/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1 |
| Molecular Structure: |
 |
| Properties |
| Density: | 1.01 g/cm3 |
| Refractive index: | 1.541 |
| Water Solubility: | Soluble to 50 mM in Ethanol |
| Solubility: | Soluble to 50 mM in Ethanol |
| Appearance: | White crystalline powder |
| Biological Activity: | Vitamin D 2 analog that acts as a vitamin D receptor activator (VDRA). |
| Usage: | Synthetic vitamin D prohormone. A new active Vitamin D analog which inhibits growth of human neuroblastoma.
Antihyperparathyroid |
| Safety Data |
| |
 |
